Royalty Pharma plc (RPRX) – Conference Calls
-
Repros Therapeutics (RPRX) Announces Cancellation of FDA Advisory Committee Review for Androxal NDA
-
Repros Therapeutics (RPRX) Moves Higher After Androxal Phase 3 Meeting w/ FDA
Back to RPRX Stock Lookup